This durg has been shown to require metabolic activation by microsmal liver enzymes to produce biologically active metabolites. The alkylated metabolites have been shown to interact with DNA & exert their cytotoxic effect. It is routinely given with mesna to reduce urothelial toxicity.
Germ cell tumors, lymphomas, sarcomas, cervical ovarian, lung and breast cancer.
Thrombocytopenia, severe leucopenia, severe renal or hepatic impairment, hypersensitivity, bone-marrow depression.
Haemorrhagic cystitis, nausea, anorexia, hallucination, somnolence, confusion, leucopenia, immunosuppresession, delayed wound healing.
Hepatic or renal impairment, haematological impairment (monitor). Ensure adequate hydration. Recent post operative (10-14 days). Carcinogenic potential.
Infused IV over atleast 30min at a dose of 1.2g/sq.m/day x 5 days, treatment cycles repeated every 3-4 weeks, monitoring hematological picture periodically.
Mean terminal elimination half-life 15 hours.
1gm
Injection (single vial per box).
Shree Ganesh
Pharmaceuticals
|
|||||||||||||
|
Disclaimer
: This guide is provided for information purposes only, and for use
of a registered medical practitioner or a hospital or a laboratory only.
The authors, webmaster, or respective references / links are no way
responsible for the content of the information. Although a concerted
effort has been made to ensure the validity of the information contained
in this document, we give no
assurance for the accuracy of the information in this documents. |